Citation Impact
Citing Papers
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Immunotherapy of cancer in 2012
2012
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
2019
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Perforin Is a Major Contributor to NK Cell Control of Tumor Metastasis
1999
John Snow's legacy: epidemiology without borders
2013 StandoutNobel
Inhibition of autophagy with chloroquine is effective in melanoma
2013
The polarization of immune cells in the tumour environment by TGFβ
2010
Friends or foes — bipolar effects of the tumour stroma in cancer
2004
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Wound healing and its impairment in the diabetic foot
2005 Standout
Mesenchymal Stem Cells in the Pathogenesis and Therapy of Breast Cancer
2010
Paracrine Regulation of Matrix Metalloproteinase Expression in Endometriosis
2002
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Natural killer cell–directed therapies: moving from unexpected results to successful strategies
2008
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
2001
Cancer Metastasis: Building a Framework
2006 Standout
Endometriosis
2009 Standout
Guillain-Barré syndrome
2016 Standout
The Human T Cell Response to Melanoma Antigens
2006
MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis
2002
The biology of VEGF and its receptors
2003 Standout
An anti‐ganglioside antibody‐secreting hybridoma induces neuropathy in mice
2004
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Lymphangiogenesis in development and human disease
2005 StandoutNature
Evolution of a designed protein assembly encapsulating its own RNA genome
2017 StandoutNatureNobel
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity
2006
Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells
2008
Taming cancer by inducing immunity via dendritic cells
2007
The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions
1997
Protective and Damaging Effects of Stress Mediators
1998 Standout
Effector and regulatory events during natural killer–dendritic cell interactions
2006
Engineering targeted viral vectors for gene therapy
2007
Immunity, Inflammation, and Cancer
2010 Standout
The immunological consequences of photodynamic treatment of cancer, a literature review
2003
An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence
2010 StandoutNobel
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Prospects for the use of NK cells in immunotherapy of human cancer
2007
A cornucopia of human polyomaviruses
2013
Targeting autophagy in cancer
2017 Standout
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Single luminal epithelial progenitors can generate prostate organoids in culture
2014
Immune evasion of microsatellite unstable colorectal cancers
2010
Angiogenesis as a therapeutic target
2005 StandoutNature
Intravital fluorescence microscopy in pulmonary research
2006
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Guillain-Barré syndrome
2005 Standout
Modeling Development and Disease with Organoids
2016 Standout
An immune-active tumor microenvironment favors clinical response to ipilimumab
2011
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
Synergistic Activation of Innate Immunity by Double-Stranded RNA and CpG DNA Promotes Enhanced Antitumor Activity
2004
Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
2012 Standout
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing
2009 StandoutNobel
A Contribution of Mouse Dendritic Cell–Derived IL-2 for NK Cell Activation
2004
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
Natural-killer cells and dendritic cells: “l'union fait la force”
2005
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Expansion of Functional NK Cells in Multiple Tissue Compartments of Mice Treated with Flt3-Ligand: Implications for Anti-Cancer and Anti-Viral Therapy
1998
Natural Killer Cell IFN-γ Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor–Bearing Patients
2009
Natural killer cell–dendritic cell crosstalk in the initiation of immune responses
2005
Cancer Genome Landscapes
2013 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
α3β1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression
2005
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
KIR and disease: a model system or system of models?
2006
Works of Per Basse being referenced
Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor Regression
2012
Regenerative Therapy and Cancer: In Vitro and In Vivo Studies of the Interaction Between Adipose-Derived Stem Cells and Breast Cancer Cells from Clinical Isolates
2010
Antitumor Activity of NK Cells
2006
Natural killer cells infiltrating colorectal cancer and MHC class I expression
2004
Establishment of Cell-to-Cell Contact by Adoptively Transferred Adherent Lymphokine-Activated Killer Cells With Metastatic Murine Melanoma Cells
1991
Natural killer–dendritic cell cross-talk in cancer immunotherapy
2005
NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
2003
Tumor disposition of pegylated liposomal CKD-602 and the reticuloendothelial system in preclinical tumor models
2010
Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors
2000
Pharmacologic Administration of Interleukin‐2
2009
Characteristics of tumor infiltration by adoptively transferred and endogenous natural-killer cells in a syngeneic rat model: Implications for the mechanism behind anti-tumor responses
1998
Merkel Cell Polyomavirus Large T Antigen Disrupts Lysosome Clustering by Translocating Human Vam6p from the Cytoplasm to the Nucleus
2011
Helper role of NK cells during the induction of anticancer responses by dendritic cells
2004
Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer
2000
The microscopic anatomy of experimental rat CC531 colon tumour metastases: Consequences for immunotherapy?
2000
Secreted and Membrane-Associated Matrix Metalloproteinases of IL-2-Activated NK Cells and Their Inhibitors
2000
Therapeutic Activity of NK Cells against Tumors
2001
In situ localization of 3.2.3+ natural killer cells in tissues from normal and tumor-bearing rats.
1991
Antitumor Functions of Natural Killer Cells and Control of Metastases
1996
Regenerated Luminal Epithelial Cells Are Derived from Preexisting Luminal Epithelial Cells in Adult Mouse Prostate
2011
Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases.
1991
Natural killer cells and gene therapy: potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases.
1994